Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AYTU
ESLA
Add up to 3 more stocks
AYTU
Aytu BioPharma, Inc.
+0.98%
$2.06+0.02Delayed quote: Oct 6, 2026, 12:48 PM EDT
Market Cap
$22.11M
52W Range
$1.80 - $3.07
ESLA
Estrella Immunopharma, Inc.
-6.20%
$0.41-0.03Delayed quote: Oct 6, 2026, 1:13 PM EDT
Market Cap
$17.61M
52W Range
$0.43 - $3.15
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.63 | N/A |
| P/S Ratio | 0.38 | N/A |
| P/FCF Ratio | 6.80 | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 64.0% | 0.0% |
| Operating Margin | -14.4% | 0.0% |
| Net Margin | -24.8% | 0.0% |
| ROE | -40.4% | N/A |
| ROA | -13.6% | -548.7% |
| ROIC | -14.2% | N/A |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.13 | 0.20 |
| Quick Ratio | 1.00 | 0.20 |
| Debt/Equity | 0.51 | N/A |
| Interest Coverage | 4.39 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.